Home Cart 0 Sign in  
X

[ CAS No. 31576-51-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 31576-51-9
Chemical Structure| 31576-51-9
Chemical Structure| 31576-51-9
Structure of 31576-51-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 31576-51-9 ]

Related Doc. of [ 31576-51-9 ]

Alternatived Products of [ 31576-51-9 ]

Product Details of [ 31576-51-9 ]

CAS No. :31576-51-9 MDL No. :MFCD09032941
Formula : C5H13NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :QWCGXANSAOXRFE-UHFFFAOYSA-N
M.W : 119.16 Pubchem ID :520530
Synonyms :

Calculated chemistry of [ 31576-51-9 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 5
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 31.03
TPSA : 44.48 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.84 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.65
Log Po/w (XLOGP3) : -1.15
Log Po/w (WLOGP) : -0.39
Log Po/w (MLOGP) : -0.65
Log Po/w (SILICOS-IT) : -0.06
Consensus Log Po/w : -0.12

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : 0.48
Solubility : 356.0 mg/ml ; 2.99 mol/l
Class : Highly soluble
Log S (Ali) : 0.71
Solubility : 608.0 mg/ml ; 5.11 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : -0.96
Solubility : 13.1 mg/ml ; 0.11 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.04

Safety of [ 31576-51-9 ]

Signal Word:Danger Class:6.1
Precautionary Statements:P210-P264-P270-P280-P301+P310+P330-P370+P378-P403+P235-P405-P501 UN#:2810
Hazard Statements:H227-H301 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 31576-51-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 31576-51-9 ]
  • Downstream synthetic route of [ 31576-51-9 ]

[ 31576-51-9 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 179820-15-6 ]
  • [ 31576-51-9 ]
YieldReaction ConditionsOperation in experiment
62% With hydrazine hydrate In ethanol at 100℃; for 3 h; Reflux 2.2.1.3 Synthesis of 2-(2-methoxyethoxy)ethylamine (2d) A mixture of N-[2-(2-methoxyethoxy)ethyl]phthalimide (2c) (27 mmol) and hydrazine monohydrate (43 mmol) in EtOH (30 mL) was refluxed at 100 °C for 3 h. After cooling down to room temperature, the mixture was filtered and the filtrate was evaporated. Acetone (50 mL) was added to the residue and the precipitate was filtered. Subsequently, the filtrate was concentrated under reduced pressure.2d was obtained as an orange oil. Yield: 62percent. 1H NMR (500 MHz, CDCl3): δ 1.83 (s, 1H), 2.00 (s, 1H), 2.15 (s, 1H), 2.87 (t, J = 5.3 Hz, 1H), 3.35-3.39 (m, 2H), 3.41 (t, J = 6.4 Hz, 1H), 3.50 (t, J = 5.3 Hz, 1H), 3.52-3.55 (m, 2H), 3.60 (dd, J = 5.7, 3.3 Hz, 1H), 3.64 (dd, J = 5.6, 3.8 Hz, 1H), 3.73 (t, J = 6.5 Hz, 1H) ppm; HR ESI-MS (in MeOH): m/z [M+H]+ Calc. 120.0973, found 120.1047.
Reference: [1] Journal of Organic Chemistry, 2011, vol. 76, # 6, p. 1683 - 1691
[2] Journal of Organic Chemistry, 2010, vol. 75, # 3, p. 598 - 610
[3] Inorganica Chimica Acta, 2016, vol. 452, p. 159 - 169
[4] Patent: WO2009/109035, 2009, A1, . Location in patent: Page/Page column 57-58
  • 2
  • [ 111-77-3 ]
  • [ 31576-51-9 ]
YieldReaction ConditionsOperation in experiment
44%
Stage #1: With phthalimide; triphenylphosphine; diethylazodicarboxylate In tetrahydrofuran; toluene at 20℃;
Stage #2: With hydrazine hydrate In ethanolReflux
Diethylene glycol monomethyl ether (3.9 mL, 33.3 mmol) and diethyl azodicarboxylate (2.2 mol/L toluenesolution) (15.5 mL, 34.1 mmol) were added to a solution of phthalimide (4.90 g, 34.2 mmol) and triphenylphosphine(9.00 g, 34.2 mmol) in tetrahydrofuran (180 mL) at room temperature, and stirred overnight. To the resulting solution,ethanol (60 mL) was further added, stirred at room temperature for 30 minutes, and then the solvent was distilled awayunder a reduced pressure. Ethyl acetate (50 mL) and hexane (50 mL) were added to the residue, and insolubles werefiltered off. After the filtrate was concentrated under a reduced pressure, ethanol (120 mL) and hydrazine monohydrate(2.4 mL, 68.6 mmol) were added, and stirred under heat reflux overnight. After this solution was cooled to room temperature,concentrated hydrochloric acid (15 mL) was added, and stirred under heat reflux for 1 hour. After this solutionwas cooled to room temperature, insolubles were filtered off, and the filtrate was concentrated under a reduced pressure.Water was added to the residue, which was washed with diethyl ether. The aqueous layer was adjusted to pH = 13 witha 3N sodium hydroxide aqueous solution, and extraction was carried out with dichloromethane. The organic layer wasdried with anhydrous sodium sulfate, the solvent was distilled away under a reduced pressure to obtain the title compound(1.74 g, 44percent) as a pale yellow oily matter.1H NMR (400 MHz, CDCl3) δ 3.64-3.61 (2H, m), 3.57-3.55 (2H, m), 3.51 (2H, t, J = 5.2 Hz), 3.39 (3H, s), 2.89-2.87 (2H, m).
Reference: [1] Patent: EP3127900, 2017, A1, . Location in patent: Paragraph 0142; 0143
[2] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 7, p. 1381 - 1384
[3] Journal of the American Oil Chemists' Society, 1996, vol. 73, # 1, p. 79 - 86
[4] Journal of Medicinal Chemistry, 1995, vol. 38, # 7, p. 1067 - 1083
[5] Journal of the American Chemical Society, 1994, vol. 116, # 12, p. 5057 - 5062
[6] J. Gen. Chem. USSR (Engl. Transl.), 1970, vol. 40, p. 1598 - 1602[7] Zhurnal Obshchei Khimii, 1970, vol. 40, # 7, p. 1611 - 1616
[8] Chemische Berichte, 1979, vol. 112, p. 1392 - 1399
[9] Journal of Organic Chemistry, 2011, vol. 76, # 6, p. 1683 - 1691
[10] Angewandte Chemie - International Edition, 2012, vol. 51, # 5, p. 1152 - 1155
[11] Patent: EP2439204, 2012, A1,
[12] Macromolecules, 2012, vol. 45, # 12, p. 5151 - 5156
[13] Inorganica Chimica Acta, 2016, vol. 452, p. 159 - 169
[14] Journal of the American Chemical Society, 2017, vol. 139, # 17, p. 6234 - 6241
[15] MedChemComm, 2017, vol. 8, # 3, p. 662 - 672
[16] Patent: WO2009/109035, 2009, A1,
  • 3
  • [ 215181-61-6 ]
  • [ 31576-51-9 ]
Reference: [1] Journal of the American Oil Chemists' Society, 1996, vol. 73, # 1, p. 79 - 86
[2] Macromolecules, 2012, vol. 45, # 12, p. 5151 - 5156
[3] MedChemComm, 2017, vol. 8, # 3, p. 662 - 672
[4] Journal of the American Chemical Society, 1994, vol. 116, # 12, p. 5057 - 5062
[5] Journal of Medicinal Chemistry, 1995, vol. 38, # 7, p. 1067 - 1083
[6] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 7, p. 1381 - 1384
[7] Patent: EP2439204, 2012, A1, . Location in patent: Page/Page column 52
[8] Macromolecules, 2012, vol. 45, # 3, p. 1362 - 1374
  • 4
  • [ 50586-80-6 ]
  • [ 31576-51-9 ]
Reference: [1] European Journal of Organic Chemistry, 2010, # 21, p. 3991 - 4003
[2] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 7, p. 1381 - 1384
[3] Journal of the American Oil Chemists' Society, 1996, vol. 73, # 1, p. 79 - 86
[4] Journal of the American Chemical Society, 1994, vol. 116, # 12, p. 5057 - 5062
[5] Journal of Organic Chemistry, 2011, vol. 76, # 6, p. 1683 - 1691
[6] Angewandte Chemie - International Edition, 2012, vol. 51, # 5, p. 1152 - 1155
[7] Patent: EP2439204, 2012, A1,
[8] Macromolecules, 2012, vol. 45, # 3, p. 1362 - 1374
[9] Macromolecules, 2012, vol. 45, # 12, p. 5151 - 5156
[10] Inorganica Chimica Acta, 2016, vol. 452, p. 159 - 169
  • 5
  • [ 194941-16-7 ]
  • [ 31576-51-9 ]
Reference: [1] Patent: US2010/298351, 2010, A1, . Location in patent: Page/Page column 35
  • 6
  • [ 684221-36-1 ]
  • [ 31576-51-9 ]
Reference: [1] Patent: US2004/87601, 2004, A1, . Location in patent: Page 29
  • 7
  • [ 54149-17-6 ]
  • [ 31576-51-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1995, vol. 38, # 7, p. 1067 - 1083
  • 8
  • [ 52808-36-3 ]
  • [ 31576-51-9 ]
Reference: [1] Chemische Berichte, 1979, vol. 112, p. 1392 - 1399
[2] J. Gen. Chem. USSR (Engl. Transl.), 1970, vol. 40, p. 1598 - 1602[3] Zhurnal Obshchei Khimii, 1970, vol. 40, # 7, p. 1611 - 1616
  • 9
  • [ 60696-83-5 ]
  • [ 31576-51-9 ]
Reference: [1] Journal of the American Chemical Society, 2017, vol. 139, # 17, p. 6234 - 6241
[2] MedChemComm, 2017, vol. 8, # 3, p. 662 - 672
  • 10
  • [ 179820-15-6 ]
  • [ 1445-69-8 ]
  • [ 31576-51-9 ]
Reference: [1] Angewandte Chemie - International Edition, 2012, vol. 51, # 5, p. 1152 - 1155
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 31576-51-9 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 2752-17-2

[ 2752-17-2 ]

2,2'-Oxydiethanamine

Similarity: 0.93

Chemical Structure| 60792-79-2

[ 60792-79-2 ]

2,2'-Oxybis(ethylamine) dihydrochloride

Similarity: 0.87

Chemical Structure| 944561-44-8

[ 944561-44-8 ]

2-[2-(2-Propynyloxy)ethoxy]ethylamine

Similarity: 0.78

Chemical Structure| 38256-93-8

[ 38256-93-8 ]

2-Methoxy-N-methylethanamine

Similarity: 0.71

Chemical Structure| 70384-51-9

[ 70384-51-9 ]

Tris(2-(2-methoxyethoxy)ethyl)amine

Similarity: 0.70

Ethers

Chemical Structure| 2752-17-2

[ 2752-17-2 ]

2,2'-Oxydiethanamine

Similarity: 0.93

Chemical Structure| 60792-79-2

[ 60792-79-2 ]

2,2'-Oxybis(ethylamine) dihydrochloride

Similarity: 0.87

Chemical Structure| 944561-44-8

[ 944561-44-8 ]

2-[2-(2-Propynyloxy)ethoxy]ethylamine

Similarity: 0.78

Chemical Structure| 38256-93-8

[ 38256-93-8 ]

2-Methoxy-N-methylethanamine

Similarity: 0.71

Chemical Structure| 70384-51-9

[ 70384-51-9 ]

Tris(2-(2-methoxyethoxy)ethyl)amine

Similarity: 0.70

Amines

Chemical Structure| 2752-17-2

[ 2752-17-2 ]

2,2'-Oxydiethanamine

Similarity: 0.93

Chemical Structure| 60792-79-2

[ 60792-79-2 ]

2,2'-Oxybis(ethylamine) dihydrochloride

Similarity: 0.87

Chemical Structure| 944561-44-8

[ 944561-44-8 ]

2-[2-(2-Propynyloxy)ethoxy]ethylamine

Similarity: 0.78

Chemical Structure| 38256-93-8

[ 38256-93-8 ]

2-Methoxy-N-methylethanamine

Similarity: 0.71

Chemical Structure| 70384-51-9

[ 70384-51-9 ]

Tris(2-(2-methoxyethoxy)ethyl)amine

Similarity: 0.70